Riskpilot← Back to searchSign inGet full accessKesek Diagnostik AB
ABIn liquidationOrg 5591720338General medical practice activities · NACE 8621Est. 20181 employees
Revenue 2023
SEK 51K
-70% vs 2022
EBITDA margin
52.6%
-79% vs 2022
Equity ratio
93.5%
Financial strength
Net profit 2023
SEK 88K
-12% vs 2022
| Revenue | SEK 51K | -70% |
| EBITDA | SEK 27K | -79% |
| Net profit | SEK 88K | -12% |
| Total assets | SEK 165K | -47% |
| Equity | SEK 154K | -3% |
| Employees | 1 | — |
Legal name
Kesek Diagnostik AB
Org number
5591720338
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 september 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget ska bedriva diagnostisk'radiologi; uppdrag att ha hand om och beskriva röntgenundersökningar samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 435 | 410 | 314 | 169 | 51 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 345 | 313 | 256 | 126 | 27 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 345 | 313 | 256 | 126 | 27 |
| Net financials | — | — | — | — | 1 |
| Profit before tax | 260 | 313 | 256 | 126 | 113 |
| Tax | −58 | −67 | −55 | −26 | −25 |
| Net profit | 202 | 246 | 201 | 100 | 88 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 364 | 447 | 404 | 310 | 165 |
| Equity | 252 | 298 | 259 | 159 | 154 |
| Long-term debt | 11 | 2 | 6 | 7 | 0 |
| Short-term debt | 15 | 63 | 55 | 59 | 11 |
| Total debt | 26 | 65 | 61 | 66 | 11 |
EBITDA margin
52.6%
This company
15.8%
Market median
+233% vs market
20192023
Equity ratio
93.5%
This company
38.2%
Market median
+145% vs market
20192023
Return on equity
57.3%
This company
18.4%
Market median
+211% vs market
20192023
Net profit margin
172.2%
This company
8.1%
Market median
+2026% vs market
20192023
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20192023
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MV External Signatory | External Signatory | 2022 |
AB External Signatory | External Signatory | 2022 |
AE Liquidator | Liquidator | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kesek Diagnostik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Veronica Vesterberg | External Signatory | 0 companies |
| Anna Birgitta Emanuelsson | External Signatory | 0 companies |
| Anna Elisabeth Adolfsson | Liquidator | 0 companies |